Appco Pharma Venlafaxine 150mg Tablets Recall: Missing Tab ID Risk
Appco Pharma recalls 150mg Venlafaxine Extended-Release Tablets (NDC 43598-943-90) due to missing tab ID on tablets. This could affect identification and safety for prescription use.
Recall notice
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Contact the company
What happened, in plain English
Appco Pharma is recalling 150mg Venlafaxine Extended-Release Tablets because they lack a tab ID on one side. This could lead to misidentification or safety issues for patients taking the medication. Read more at govinfonow.com/recall/32332-appco-pharma-venlafaxine-150mg-tablets-recall-missing-tab-id-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32332-appco-pharma-venlafaxine-150mg-tablets-recall-missing-tab-id-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0208-2025
Cite this page
“Appco Pharma Venlafaxine 150mg Tablets Recall: Missing Tab ID Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32332-appco-pharma-venlafaxine-150mg-tablets-recall-missing-tab-id-risk. Based on FDA recall #D-0208-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0208-2025%22&limit=1).
Why it’s dangerous
The missing tab ID on the tablet can make it difficult to identify the product correctly. This could lead to misidentification or safety concerns if the tablets are not properly distinguished from other medications.
Who’s affected
Prescription patients using the recalled Venlafaxine Extended-Release Tablets. Those with the specific lot number (2402101UR) are most at risk.
How to tell if you have this one
Check for the lot number 2402101UR on the packaging. The product is a prescription-only 150mg Venlafaxine Extended-Release Tablets with NDC 43598-943-90.
- Brand
Appco Pharma- Category
Drug
What to do — step by step
Check Product Packaging
Look for the lot number 2402101UR on the packaging to confirm if the product is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 13 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Appco Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0208-2025 (January 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0208-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.